|
Volumn 95, Issue 7, 2002, Pages 736-742
|
Attention deficit hyperactivity disorder in adults: A guide for the primary care physician
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
AMFEBUTAMONE;
AMPHETAMINE;
ANTIDEPRESSANT AGENT;
CENTRAL STIMULANT AGENT;
DESIPRAMINE;
DEXAMPHETAMINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
LITHIUM;
METHYLPHENIDATE;
MIRTAZAPINE;
NORADRENALIN UPTAKE INHIBITOR;
PAROXETINE;
PEMOLINE;
PEMOLINE MAGNESIUM;
RISPERIDONE;
SEROTONIN UPTAKE INHIBITOR;
VENLAFAXINE;
AFFECTIVE NEUROSIS;
ANAMNESIS;
ANTISOCIAL BEHAVIOR;
ATTENTION;
ATTENTION DEFICIT DISORDER;
CLINICAL FEATURE;
CLINICAL TRIAL;
COMORBIDITY;
CONFLICT;
DIFFERENTIAL DIAGNOSIS;
DISEASE COURSE;
DRUG EFFICACY;
GENETIC SUSCEPTIBILITY;
HUMAN;
MANIC DEPRESSIVE PSYCHOSIS;
MEDICAL EXAMINATION;
MENTAL PERFORMANCE;
NEUROBIOLOGY;
NEUROLOGIC EXAMINATION;
PATIENT EDUCATION;
PATIENT REFERRAL;
PHYSICIAN;
PRIMARY MEDICAL CARE;
PSYCHIATRIC DIAGNOSIS;
PSYCHIATRIC TREATMENT;
RATING SCALE;
REVIEW;
SEXUAL DYSFUNCTION;
SUBSTANCE ABUSE;
SUPPORT GROUP;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
TREATMENT OUTCOME;
WEIGHT GAIN;
|
EID: 0036064167
PISSN: 00384348
EISSN: None
Source Type: Journal
DOI: 10.1097/00007611-200207000-00015 Document Type: Review |
Times cited : (30)
|
References (21)
|